CEPI Statement on Bundibugyo Virus Vaccine R&D Gaps (cepi.net)

• No Bundibugyo virus-specific vaccine candidates in clinical trials.
• Only preclinical candidates exist for this Ebola species.
• CEPI investing in early-stage R&D to address gap.

"CEPI's statement reveals no Bundibugyo-specific Ebola vaccines are in clinical trials, only preclinical development, highlighting a critical gap in medical countermeasures. The organization is investing in early-stage R&D to address this."